Related Experiment Video

Updated: May 8, 2026

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)
12:18

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)

Published on: February 9, 2011

Mycoplasma pneumoniae-induced recurrent Stevens-Johnson syndrome in children: a case report

Cinzia Campagna1, Davide Tassinari, Iria Neri

  • 1Department of Pediatrics, S. Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy.

Pediatric Dermatology
|September 11, 2013
PubMed

Insights

Mycoplasma pneumoniae is a common cause of Stevens-Johnson syndrome (SJS) in children, even without typical pneumonia symptoms. Early identification of this infection is crucial, especially for recurrent SJS cases.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Dermatology

Background:

  • Mycoplasma pneumoniae is a significant cause of community-acquired pneumonia.
  • Stevens-Johnson syndrome (SJS) is a severe mucocutaneous reaction.
  • M. pneumoniae is increasingly recognized as a trigger for SJS in pediatric populations.

Observation:

  • A 12-year-old boy presented with Stevens-Johnson syndrome.
  • The SJS was diagnosed as being induced by Mycoplasma pneumoniae infection.
  • The patient experienced a relapse of SJS eight months post-discharge.

Findings:

  • Mycoplasma pneumoniae can cause SJS in children, independent of classical pulmonary symptoms.
  • Recurrent SJS necessitates prompt etiological investigation.
  • Identifying M. pneumoniae as the causative agent is vital for managing SJS.

Implications:

  • Clinicians should consider M. pneumoniae in pediatric SJS cases, even without respiratory signs.
  • Early diagnosis of M. pneumoniae infection can guide appropriate treatment and prevent recurrence.
  • This case highlights the importance of considering atypical pathogens in severe cutaneous adverse reactions.

Related Concept Videos

Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...